Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009

Supportive Care in Cancer

Volumn 19, Issue SUPPL. 1, 2011, Pages

  Jordan, Karin ^e   Roila, Fausto ^a   Molassiotis, Alexander ^b   Maranzano, Ernesto ^a   Clark Snow, Rebecca A ^c   Feyer, Petra ^d  

^a S MARIA HOSPITAL   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^d VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^e NONE

Author keywords

5 HT 3 receptor antagonists; Antiemetics for children submitted to chemotherapy; Dexamethasone

Indexed keywords

ANTIEMETIC AGENT; APREPITANT; CANNABINOID; CHLORPROMAZINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIMENHYDRINATE; DOPAMINE RECEPTOR BLOCKING AGENT; FOSAPREPITANT; GRANISETRON; LORAZEPAM; METOCLOPRAMIDE; METOPIMAZINE; NEUROKININ 1 RECEPTOR ANTAGONIST; ONDANSETRON; PALONOSETRON; PHENOTHIAZINE; SEROTONIN 3 ANTAGONIST; TROPISETRON;

ABSENCE OF SIDE EFFECTS; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHILD; CHILD CARE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LOADING DRUG DOSE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE;

ADOLESCENT; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; GLUCOCORTICOIDS; HUMANS; NAUSEA; RECEPTORS, NEUROKININ-1; SEROTONIN ANTAGONISTS; VOMITING;

EID: 79953306022     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-010-0994-7     Document Type: Review

References (30)

1. Alvarez O, Freeman A, Bedros A, Call SK, Volsch J, Kalbermatter O, Halverson J, Convy L, Cook L, Mick K et al (1995) Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol 17:145-150
2. Antonarakis ES, Evans JL, Heard GF, Noonan LM, Pizer BL, Hain RD (2004) Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence? Pediatr Blood Cancer 43:651-658
3. Basade M, Kulkarni SS, Dhar AK, Sastry PS, Saikia B, Advani SH (1996) Comparison of dexamethasone and metoclopramide as antiemetics in children receiving cancer chemotherapy. Indian Pediatr 33:321-323 (Pubitemid 26139797)
4. Berrak SG, Ozdemir N, Bakirci N, Turkkan E, Canpolat C, Beker B, Yoruk A (2007) A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy. Support Care Cancer 15:1163-1168 (Pubitemid 47459868)
5. Brock P, Brichard B, Rechnitzer C, Langeveld NE, Lanning M, Soderhall S, Laurent C (1996) An increased loading dose of ondansetron: a north European, double-blind randomised study in children, comparing 5 mg/m2 with 10 mg/m2. Eur J Cancer 32A:1744-1748 (Pubitemid 26306887)
6. Burger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M (2005) Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL) - experiences from trial ALL-BFM 95. Pediatr Blood Cancer 44:220-225 (Pubitemid 40209430)
7. Cappelli C, Ragni G, De Pasquale MD, Gonfiantini M, Russo D, Clerico A (2005) Tropisetron: optimal dosage for children in prevention of chemotherapy-induced vomiting. Pediatr Blood Cancer 45:48-53 (Pubitemid 40791746)
8. Corapcioglu F, Sarper N (2005) A prospective randomized trial of the antiemetic efficacy and cost-effectiveness of intravenous and orally disintegrating tablet of ondansetron in children with cancer. Pediatr Hematol Oncol 22:103-114 (Pubitemid 40315509)
9. Davies JH, Evans BA, Jenney ME, Gregory JW (2002) In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancy. Bone 31:319-326
10. Gore L, Chawla S, Petrilli A, Hemenway M, Schissel D, Chua V, Carides AD, Taylor A, Devandry S, Valentine J, Evans JK, Oxenius B (2009) Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability. Pediatr Blood Cancer 52:242-247
11. Graham-Pole J, Weare J, Engel S, Gardner R, Mehta P, Gross S (1986) Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine. J Clin Oncol 4:1110-1113 (Pubitemid 16059737)
12. Gralla RJ, Roila F, Tonato M (2005) The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants. Support Care Cancer 13:77-79 (Pubitemid 40558161)
13. Hasler SB, Hirt A, Ridolfi Luethy A, Leibundgut KK, Ammann RA (2008) Safety of ondansetron loading doses in children with cancer. Support Care Cancer 16:469-475 (Pubitemid 351502761)
14. Hirota T, Honjo T, Kuroda R, Saeki K, Katano N, Sakakibara Y, Shimizu H, Fujimoto T (1993) Antiemetic efficacy of granisetron in pediatric cancer treatment - (2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis. Gan To Kagaku Ryoho 20:2369-2373
15. Holdsworth MT, Raisch DW, Frost J (2006) Acute and delayed nausea and emesis control in pediatric oncology patients. Cancer 106:931-940 (Pubitemid 43238462)
16. Jaing TH, Tsay PK, Hung IJ, Yang CP, Hu WY (2004) Single-dose oral granisetron versus multidose intravenous ondansetron for moderately emetogenic cyclophosphamide-based chemotherapy in pediatric outpatients with acute lymphoblastic leukemia. Pediatr Hematol Oncol 21:227-235
17. Jordan K, Schmoll HJ, Aapro MS (2007) Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 61:162-175 (Pubitemid 46073781)
18. Jurgens H, McQuade B (1992) Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology 49:279-285
19. Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24:2932-2947
20. Lackner H, Benesch M, Moser A, Smolle-Juttner F, Linhart W, Raith J, Urban C (2005) Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: a 13-year longitudinal observational study. J Pediatr Hematol Oncol 27:259-263 (Pubitemid 40705805)
21. Luisi FA, Petrilli AS, Tanaka C, Caran EM (2006) Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma. São Paulo Med J 124:61-65 (Pubitemid 44194356)
22. Marshall G, Kerr S, Vowels M, O'Gorman-Hughes D, White L (1989) Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone. J Pediatr 115:156-160 (Pubitemid 19177989)
23. Mehta P, Gross S, Graham-Pole J, Gardner R (1986) Methylprednisolone for chemotherapy-induced emesis: a double-blind randomized trial in children. J Pediatr 108:774-776 (Pubitemid 16064133)
24. Morrow GR (1989) Chemotherapy-related nausea and vomiting: etiology and management. CA Cancer J Clin 39:89-104
25. Nathan PC, Tomlinson G, Dupuis LL, Greenberg ML, Ota S, Bartels U, Feldman BM (2006) A pilot study of ondansetron plus metopimazine vs. ondansetron monotherapy in children receiving highly emetogenic chemotherapy: a Bayesian randomized serial N-of-1 trials design. Support Care Cancer 14:268-276 (Pubitemid 43247931)
26. Relling MV, Mulhern RK, Fairclough D, Baker D, Pui CH (1993) Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy. J Pediatr 123:811-816
27. Roila F, Feyer P, Maranzano E, Olver I, Clark-Snow R, Warr D, Molassiotos A (2005) Antiemetics in children receiving chemotherapy. Support Care Cancer 13:129-131 (Pubitemid 40558170)
28. Schrey D, Boos J (2009) Antiemetische Therapie in der pädiatrischen. Onkol Im Focus Onkol 9:63-68
29. Sepulveda-Vildosola AC, Betanzos-Cabrera Y, Lastiri GG, Rivera-Marquez H, Villasis-Keever MA, Del Angel VW, Diaz FC, Lopez-Aguilar E (2008) Palonosetron hydrochloride is an effective and safe option to prevent chemotherapy-induced nausea and vomiting in children. Arch Med Res 39:601-606 (Pubitemid 352033608)
30. Small BE, Holdsworth MT, Raisch DW, Winter SS (2000) Survey ranking of emetogenic control in children receiving chemotherapy. J Pediatr Hematol Oncol 22:125-132 (Pubitemid 32290147)